Effects of interleukin-1 polymorphisms on susceptibility and clinical characteristics of British caucasian rheumatoid arthritis patients
Κύριοι συγγραφείς: | Harrison, P, Chapman, K, Pointon, J, Farrar, C, Harin, A, Jess, C, Wordsworth, B |
---|---|
Μορφή: | Conference item |
Έκδοση: |
2008
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
MHC2TA promoter polymorphism (-168*G/A, rs3087456) is not associated with susceptibility to rheumatoid arthritis in British Caucasian rheumatoid arthritis patients.
ανά: Harrison, P, κ.ά.
Έκδοση: (2007) -
Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients.
ανά: Harrison, P, κ.ά.
Έκδοση: (2006) -
HLA-DRB1 influence on anti-TNF treatment in British Caucasian rheumatoid arthritis patients
ανά: Harrison, P, κ.ά.
Έκδοση: (2006) -
The PTPN22 R620W polymorphism - Effects on susceptibility and clinical features on British Caucasian rheumatoid arthritis patients.
ανά: Harrison, P, κ.ά.
Έκδοση: (2005) -
Polymorphism in codon 17 of the CTLA-4 gene (+49 A/G) is not associated with susceptibility to rheumatoid arthritis in British Caucasians.
ανά: Milicic, A, κ.ά.
Έκδοση: (2001)